| Literature DB >> 32010219 |
Elizeu Teixeira Silva1, Hirondina Borges Spencer1, Victor Costa1, Ana Filipa Gonçalves2, Clara Castro2, Maria José Bento2, Carla Barbosa1,3, Lúcio Lara Santos4.
Abstract
This report describes the cancer cases that occurred between 2017 and 2018 in Santiago Island, Cape Verde, according to the Hospital Agostinho Neto Cancer Registry. The five most common cancers were prostate, breast, stomach, cervix and oesophageal in order of frequency. There are no national data. Therefore, it is essential to create the conditions for the establishment of Cape Verde's population-based cancer registry as quickly as possible. © the authors; licensee ecancermedicalscience.Entities:
Keywords: Cape Verde; Hospital Agostinho Neto; Santiago Island; cancer registry
Year: 2019 PMID: 32010219 PMCID: PMC6974378 DOI: 10.3332/ecancer.2019.995
Source DB: PubMed Journal: Ecancermedicalscience ISSN: 1754-6605
Figure 1.The Santiago Island population pyramid (person-year by sex and age group).
Number of cases by site, age group and percentage: males.
| Site | ALL | Age | Age group (years) | % | ICD-10 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| age | unk | 0- | 5- | 10- | 15- | 20- | 25- | 30- | 35- | 40- | 45- | 50- | 55- | 60- | 65- | 70- | 75+ | |||
| Mouth | 7 | - | - | - | - | - | - | - | 2 | - | - | - | 1 | 3 | - | - | - | 1 | 3,4% | C00-06 |
| Salivary gland | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | 0,5% | C07-08 |
| Nasopharynx | 2 | - | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 1,0% | C11 |
| Other pharynx | 4 | - | - | - | - | - | - | - | - | - | 1 | 1 | - | 1 | - | - | - | 1 | 2,0% | C09-10, C12-14 |
| Oesophagus | 24 | - | - | - | - | - | - | - | - | - | 2 | 3 | 4 | 6 | 4 | 2 | 1 | 2 | 11,8% | C15 |
| Stomach | 22 | - | - | - | - | - | - | - | - | - | - | 4 | 4 | 6 | 1 | 2 | - | 5 | 10,8% | C16 |
| Colon | 6 | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | - | 1 | 1 | - | 1 | 2,9% | C18 |
| Rectum | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | 0,5% | C19-20 |
| Anus | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | 0,5% | C21 |
| Liver | 11 | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 2 | 4 | - | - | - | 1 | 5,4% | C22 |
| Gallbladder etc. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C23-24 |
| Pancreas | 7 | - | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 2 | - | - | 2 | 3,4% | C25 |
| Larynx | 8 | - | - | - | - | - | - | - | - | - | 1 | 3 | 1 | - | 2 | - | 1 | - | 3,9% | C32 |
| Trachea, bronchus and lung | 13 | - | - | - | - | - | - | - | - | 1 | - | 3 | 1 | 2 | 1 | 1 | 2 | 2 | 6,4% | C33-34 |
| Bone | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C40-41 |
| Melanoma of skin | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | 0,5% | C43 |
| Non-melanoma skin | 1 | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | - | 0,5% | C44 |
| Mesothelioma | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C45 |
| Kaposi sarcoma | 2 | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | 1 | - | - | 1,0% | C46 |
| Connective and soft tissue | 3 | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - | - | 1 | 1,5% | C47, C49 |
| Breast | 1 | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | - | 0,5% | C50 |
| Penis | 4 | - | - | - | - | - | - | - | - | 1 | - | 1 | - | - | - | - | 1 | 1 | 2,0% | C60 |
| Prostate | 68 | - | - | - | - | - | - | - | - | - | - | 3 | 4 | 5 | 6 | 10 | 8 | 32 | 33,3% | C61 |
| Testis | 1 | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,5% | C62 |
| Kidney and renal pelvis | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | 0,5% | C64-65 |
| Bladder | 3 | - | - | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | - | - | - | 1,5% | C67 |
| Ureter and other urinary | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C66, C68 |
| Eye | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C69 |
| Brain and nervous system | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | 0,5% | C70-72 |
| Thyroid | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | 0,5% | C73 |
| Hodgkin lymphoma | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | 0,5% | C81 |
| Non-Hodgkin | 5 | - | 1 | - | - | - | - | - | 1 | - | - | - | - | 1 | 1 | - | - | 1 | 2,5% | C82-85, C96 |
| Multiple myeloma | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C90 |
| Lymphoid leukaemia | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C91 |
| Myeloid leukaemia | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C92-94 |
| Leukaemia, | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | C95 |
| Other and | 5 | - | - | - | - | - | - | - | - | - | 1 | 1 | 2 | - | - | - | - | 1 | 2,5% | O&U |
| All sites | 205 | - | 2 | - | - | - | - | 1 | 4 | 3 | 9 | 23 | 24 | 35 | 19 | 17 | 15 | 53 | C00-96 | |
| All sites except C44 | 204 | - | 2 | - | - | - | - | 1 | 4 | 3 | 9 | 23 | 23 | 35 | 19 | 17 | 15 | 53 | 100,0% | C00-96 exc. C44 |
Number of cases by site age group and percentage: females.
| Site | ALL | Age | Age group (years) | % | ICD-10 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| age | unk | 0- | 5- | 10- | 15- | 20- | 25- | 30- | 35- | 40- | 45- | 50- | 55- | 60- | 65- | 70- | 75+ | |||
| Mouth | 3 | - | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - | 1 | 1,6% | C00-06 |
| Salivary gland | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C07-08 |
| Nasopharynx | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C11 |
| Other pharynx | 3 | - | - | - | - | - | - | - | - | - | - | - | 1 | 2 | - | - | - | - | 1,6% | C09-10, C12-14 |
| Oesophagus | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | 0,5% | C15 |
| Stomach | 19 | - | - | - | - | - | - | - | - | - | 1 | - | 2 | 2 | 1 | - | 5 | 8 | 9,9% | C16 |
| Colon | 3 | - | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | - | - | - | - | 1,6% | C18 |
| Rectum | 7 | - | - | - | - | - | - | - | 1 | 1 | - | 3 | - | - | 2 | - | - | - | 3,6% | C19-20 |
| Anus | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C21 |
| Liver | 3 | - | - | - | - | - | - | - | 1 | - | - | - | - | - | 1 | - | - | 1 | 1,6% | C22 |
| Gallbladder etc. | 3 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 1 | 1,6% | C23-24 |
| Pancreas | 14 | - | - | - | - | - | - | - | - | - | - | 1 | - | 2 | 2 | 1 | 2 | 6 | 7,3% | C25 |
| Larynx | 1 | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | 0,5% | C32 |
| Trachea, bronchus and lung | 7 | - | - | - | - | - | - | - | - | - | - | 1 | 1 | - | - | - | - | 5 | 3,6% | C33-34 |
| Bone | 1 | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | - | 0,5% | C40-41 |
| Melanoma of skin | 2 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | 1,0% | C43 |
| Non-melanoma skin | 2 | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | 1,0% | C44 |
| Mesothelioma | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C45 |
| Kaposi sarcoma | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C46 |
| Connective and soft tissue | 2 | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | 1,0% | C47, C49 |
| Breast | 49 | - | - | - | - | - | - | - | 3 | 4 | 9 | 7 | 7 | 6 | 5 | 2 | 1 | 5 | 25,5% | C50 |
| Vulva | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C51 |
| Vagina | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C52 |
| Cervix uteri | 40 | - | - | - | - | - | - | 1 | 4 | 4 | 4 | 4 | 10 | 5 | 5 | 2 | - | 1 | 20,8% | C53 |
| Uterus | 2 | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - | 1,0% | C54-55 |
| Ovary | 4 | - | - | - | - | 1 | - | - | - | 1 | - | - | - | - | - | 1 | - | 1 | 2,1% | C56 |
| Placenta | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C58 |
| Kidney and renal pelvis | 2 | - | - | - | - | - | - | - | - | - | - | - | - | 1 | 1 | - | - | - | 1,0% | C64-65 |
| Bladder | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C67 |
| Ureter and other urinary | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C66, C68 |
| Eye | 1 | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | - | 0,5% | C69 |
| Brain and nervous system | 4 | - | - | 1 | - | 1 | 1 | - | - | - | - | - | - | - | - | 1 | - | - | 2,1% | C70-72 |
| Thyroid | 7 | - | - | - | - | - | 1 | - | - | - | 2 | 1 | 2 | - | - | - | - | 1 | 3,6% | C73 |
| Hodgkin lymphoma | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,0% | C81 |
| Non-Hodgkin lymphoma | 6 | - | 2 | - | - | - | - | - | - | - | - | - | - | 3 | 1 | - | - | - | 3,1% | C82-85, C96 |
| Multiple myeloma | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | 0,5% | C90 |
| Lymphoid leukaemia | 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2 | 1,0% | C91 |
| Myeloid leukaemia | 2 | - | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - | - | 1,0% | C92-94 |
| Leukaemia, | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | 0,5% | C95 |
| Other and | 2 | - | - | - | - | - | - | 1 | - | - | - | - | 1 | - | - | - | - | - | 1,0% | O&U |
| All sites | 194 | - | 2 | 1 | - | 2 | 2 | 2 | 11 | 10 | 18 | 21 | 27 | 25 | 23 | 8 | 10 | 32 | C00-96 | |
| All sites except C44 | 192 | - | 2 | 1 | - | 2 | 2 | 2 | 11 | 10 | 17 | 21 | 27 | 24 | 23 | 8 | 10 | 32 | 100,0% | C00-96 exc. C44 |